barr 400mg 590 Pill - red & white capsule/oblong, 23mm
Pill with imprint barr 400mg 590 is Red & White, Capsule/Oblong and has been identified as Didanosine 400 mg. It is supplied by Teva Pharmaceuticals USA.
Didanosine is used in the treatment of HIV Infection; Nonoccupational Exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Didanosine 400 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for barr 400mg 590
Didanosine
- Imprint
- barr 400mg 590
- Strength
- 400 mg
- Color
- Red & White
- Size
- 23.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- Inactive Ingredients
-
ferrosoferric oxide,
croscarmellose sodium,
D&C Yellow No. 10,
FD&C Blue No. 1,
FD&C Blue No. 2,
indigotindisulfonate sodium,
FD&C Red No. 40,
hypromellose 2910 (3 mPa.s),
hypromellose 2910 (6 mPa.s),
hypromellose 2910 (50 mPa.s),
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
microcrystalline cellulose,
polydextrose,
polyethylene glycol 8000,
propylene glycol,
shellac,
silicon dioxide,
sodium hydroxide,
magnesium silicate,
titanium dioxide,
triacetin,
triethyl citrate,
D&C Red No. 33,
FD&C Yellow No. 6
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00555-0590 (Discontinued) | Barr Laboratories, Inc. |
| 35356-0259 | Lake Erie Medical and Surgical Supply (repackager) |
| 54569-5643 (Discontinued) | A-S Medication Solutions, LLC (repackager) |
See also:
More about didanosine
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
- Breastfeeding
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.